A multicenter, open-label feasibility study of daratumumab with dose-adjusted EPOCH in newly diagnosed plasmablastic lymphoma: AIDS Malignancy Consortium 105 Meeting Abstract
| Authors: | Tan, C. R.; Barta, S. K.; Lensing, S. Y.; Noy, A. |
| Abstract Title: | A multicenter, open-label feasibility study of daratumumab with dose-adjusted EPOCH in newly diagnosed plasmablastic lymphoma: AIDS Malignancy Consortium 105 |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160402147 |
| DOI: | 10.1182/blood-2019-129702 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1595 -- Source: Wos |
